- Home
- EDVA vs SCNI Comparison
EDVA vs SCNI Comparison
Compare EDVA & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDVA | SCNI |
|---|---|---|
| Founded | N/A | 2003 |
| Country | | Israel |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.7M |
| IPO Year | 2012 | 2014 |
Fundamental Metrics
Financial Performance| Metric | EDVA | SCNI |
|---|---|---|
| Price | $0.26 | $1.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 236.1K | ★ 1.2M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.30 | ★ 50.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $73,066.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.23 | $0.21 |
| 52 Week High | $0.32 | $3.58 |
Technical Indicators
Market Signals| Indicator | EDVA | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 28.45 | 49.80 |
| Support Level | $0.23 | $0.36 |
| Resistance Level | N/A | $3.58 |
| Average True Range (ATR) | 0.03 | 0.21 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 29.19 | 12.60 |
Price Performance
Historical ComparisonAbout EDVA Endovia Health Sciences Inc. Common Stock
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.